Ferhatbegović, Lamija http://orcid.org/0000-0002-1728-0649
Mršić, Denis
Kušljugić, Sabina
Pojskić, Belma
Article History
Accepted: 5 April 2022
First Online: 28 May 2022
Declarations
:
: Lamija Ferhatbegović reports payment or honoraria from KRKA FARMA d.o.o. Sarajevo, Bayer Pharma Sarajevo, Novartis Pharma Services Inc., and Servier. They also report support for attending meetings and/or travel from Farmavita Sarajevo and KRKA FARMA d.o.o. Sarajevo.Denis Mršić reports payment or honoraria from Bosnalijek d.d Sarajevo.Sabina Kušljugić has nothing to disclose.Belma Pojskić reports payment or honoraria from KRKA FARMA d.o.o. Sarajevo, Lek d.d. Ljubljana, Novartis Pharma Services Inc., and Farmavita Sarajevo. They also report support for attending meetings and/or travel from Farmavita Sarajevo. And they report participation on a Data Safety Monitoring Board or Advisory Board for Novartis and Sanofi.
: This article is a review article in the field of low-density lipoprotein cholesterol and atherosclerotic cardiovascular disease. It contains previous publications based on human and animal studies.